Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Helbig

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Scientific Reports|January 20, 2021
Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600<sup>E/K</sup> mutated malignant melanomasSebastian Klein, Cornelia Mauch, Klaus Brinker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanomaKa-Won Noh, Yuri Tolkach, Doris Helbig, et al.
Acta Dermatovenerologica Croatica : ADC|September 25, 2022
Metabolic Signature of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Expression of Hypoxia-inducible Factor-1α and Several of Its Downstream TargetsFerdinand Toberer, Julia K Winkler, Holger A Haenssle, et al.
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Oncoimmunology|November 20, 2019
First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitorsSebastian Klein, Oana-Diana Persa, Cornelia Mauch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 31, 2023
S1-guideline cutaneous and subcutaneous leiomyosarcomaDoris Helbig, Edgar Dippel, Michael Erdmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2023
S1-Leitlinie dermales und subkutanes LeiomyosarkomDoris Helbig, Edgar Dippel, Michael Erdmann, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 15, 2024
Mitochondrial DNA mutations attenuate Bleomycin-induced dermal fibrosis by inhibiting differentiation into myofibroblastsLena Reiter, Nadine Niehoff, Daniela Weiland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to ImmunotherapySebastian Klein, Alexander Quaas, Ka-Won Noh, et al.
Plos Computational Biology|January 21, 2026
Histo-Miner: Deep learning based tissue features extraction pipeline from H&E whole slide images of cutaneous squamous cell carcinomaLucas Sancéré, Carina Lorenz, Doris Helbig, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|January 20, 2021
Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600<sup>E/K</sup> mutated malignant melanomasSebastian Klein, Cornelia Mauch, Klaus Brinker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanomaKa-Won Noh, Yuri Tolkach, Doris Helbig, et al.
Acta Dermatovenerologica Croatica : ADC|September 25, 2022
Metabolic Signature of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Expression of Hypoxia-inducible Factor-1α and Several of Its Downstream TargetsFerdinand Toberer, Julia K Winkler, Holger A Haenssle, et al.
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Oncoimmunology|November 20, 2019
First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitorsSebastian Klein, Oana-Diana Persa, Cornelia Mauch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 31, 2023
S1-guideline cutaneous and subcutaneous leiomyosarcomaDoris Helbig, Edgar Dippel, Michael Erdmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2023
S1-Leitlinie dermales und subkutanes LeiomyosarkomDoris Helbig, Edgar Dippel, Michael Erdmann, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 15, 2024
Mitochondrial DNA mutations attenuate Bleomycin-induced dermal fibrosis by inhibiting differentiation into myofibroblastsLena Reiter, Nadine Niehoff, Daniela Weiland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to ImmunotherapySebastian Klein, Alexander Quaas, Ka-Won Noh, et al.
Plos Computational Biology|January 21, 2026
Histo-Miner: Deep learning based tissue features extraction pipeline from H&E whole slide images of cutaneous squamous cell carcinomaLucas Sancéré, Carina Lorenz, Doris Helbig, et al.
Pageof 6